Top View
- Antibiotics Currently in Clinical Development Note: This Data Visualization Was Updated in May 2017 with New Data
- Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused By
- Treatment of Carbapenem Resistant Gram Negative Infections
- Beta-Lactam Allergy Tip Sheet
- Piperacillin-Tazobactam Use in Scottish Acute Hospitals
- Shionogi Briefing Document
- Zac4943-2Ch105t.Pdf
- Piperacillin–Tazobactam As Alternative to Carbapenems for ICU Patients
- Piperacillin-Tazobactam Use in Scottish Acute Hospitals
- SVARM|2008 Swedish Veterinary Antimicrobial Resistance Monitoring 2 SVARM|2008
- Penicillin Allergy Cross-‐Reactivity • Roughly 10% of the Population
- Antimicrobial Prescribing: Cefiderocol
- Molecular Diversity of Extended-Spectrum Β-Lactamases and Carbapenemases, and Antimicrobial Resistance Teiji Sawa1* , Kunihiko Kooguchi2 and Kiyoshi Moriyama3
- Successful Use of Repurposed Drugs for MDR TB: Meropenem/Clavulanate and Its Newer Rela Ves
- Consecutive Radical S-Adenosylmethionine Methylations Form the Ethyl Side Chain in Thienamycin Biosynthesis
- Antibiotic Consumption in Hospitalized Children at the University Clinic for Pediatric Diseases – Skopje
- Joint Report on Human and Animal Antibiotic Use, Sales and Resistance, 2013
- Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs Against Acinetobacter Baumannii
- Inhibition of Class a and C Β-Lactamases
- CARBAPENEM RESISTANCE from Diagnosis to Outbreak Management TABLE of CONTENTS INTRODUCTION
- Mode of Action of Cefiderocol, a Novel Siderophore Cephalosporin, Active
- Antibiotics in the Clinical Pipeline in October 2019
- Versus Meropenem/Clavulanate-Containing Regimens in the Treatment of MDR- and XDR-TB
- 20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: an Update from the Infectious Diseases Society of America
- A Review on Β-Lactam Antibiotic Drug Resistance
- Cefiderocol), Has Been Selected by Uk’S Nice / Nhse&I As Part of an Antimicrobial Subscription Style Reimbursement Model
- Use of Carbapenems in Children Summary Carbapenems Are Betalactams with the Broadest Antibacterial Spectrum Currently Available
- Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: a Systematic Review with Meta-Analysis
- Carbapenem Antibiotics for Serious Infections Peter M Hawkey,1 2 David M Livermore3 4
- Carbapenem-Sparing Strategies for ESBL Producers: When and How
- Efficacy and Safety of Cefiderocol Or Best Available Therapy for The
- Penicillin Allergy Is Often Over Reported
- Transcriptome-Based Design of Antisense Inhibitors Potentiates Carbapenem Efficacy in CRE Escherichia Coli
- Carbapenem-Resistant Enterobacteriaceae
- Differential Active Site Requirements for NDM-1 ОІ-Lactamase Hydrolysis Of
- The Biosynthetic Gene Cluster for the ß-Lactam Carbapenem
- List Item ECDC, EFSA and EMA Joint Scientific Opinion on a List of Outcome Indicators As
- Full-Text PDF (Final Published Version)
- Antibiotic Consumption and Healthcare-Associated Infections in a Tertiary Hospital in Belgrade, Serbia from 2011 to 2016
- The Effect of Antibiotic Use on Prevalence of Nosocomial Vancomycin-Resistant Enterococci- an Ecologic Study Cornelius Remschmidt*, Michael Behnke, Axel Kola, Luis A
- 2016 Norm Norm-Vet
- Efficacy of Polymyxins in the Treatment of Carbapenem-Resistant
- Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
- Vital Signs: Carbapenem-Resistant Enterobacteriaceae
- The Clinical Potential of Antimicrobial Peptides
- First Successful Use of Low Dose Amoxicillin-Clavulanic Acid In
- Swedres-Svarm 2015
- Carbapenem Resistance: a Review
- Norm Norm-Vet 2015
- Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella Pneumoniae
- An Overview of Beta-Lactam Antibiotics Bearing More Than One Pharmacophoric Group
- Sales of Veterinary Antimicrobial Agents in 29 European Countries in 2014
- Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use
- Carbapenem-Resistant Enterobacteriaceae Threat Level Urgent
- The Use of Cephalosporins and Carbapenems in Penicillin-Allergic Patients Stephanie J
- New Carbapenemase Inhibitors: Clearing the Way for the -Lactams
- 2018 Update of Antibacterial Agents in Clinical Development Is Based on the Outcome of the Second Advisory Group Meeting That Was Held on 12 July 2018
- Colistin 1 Colistin
- Producing Enterobacteriaceae †